Aibotics Inc. (AIBT)
OTCMKTS · Delayed Price · Currency is USD
0.0014
+0.0004 (40.00%)
Feb 12, 2026, 2:47 PM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $717.45 thousand as of February 12, 2026. Its market cap has increased by 1,268.66% in one year.
Market Cap
717.45K
Enterprise Value
1.97M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 717.45K, a decrease of -98.29%. That is a compound annual growth rate of -55.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 717.45K | -41.06% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
| Jan 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 878.42K |
| EV Biologics | 840.53K |
| Protagenic Therapeutics | 732.60K |
| Altamira Therapeutics | 718.01K |
| SQZ Biotechnologies Company | 707.79K |
| Sorrento Therapeutics | 706.83K |
| Avenue Therapeutics | 631.21K |
| Bio-Path Holdings | 609.98K |